Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (5): 704-708    DOI: 10.12891/ceog4723.2019
Original Research Previous articles | Next articles
Intraoperative infrarenal aortic balloon occlusion in pregnancies with placenta accreta, increta, and percreta
Z.R. Zheng1, X. Xie1, Y. Hou1, P. Xie2, X. Yu2, L. Xie1, *()
1Department of Obstetrics and Gynecology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
2Department of Interventional Radiology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
Download:  PDF(479KB)  ( 307 ) Full text   ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Objective: The objective of this study was to evaluate the efficacy of intraoperative aortic balloon occlusion (IABO) during cesarean section for placenta accreta, increta or percreta. Materials and Methods: This was a retrospective case-control study of patients with surgically or pathologically confirmed placenta accreta, increta or percreta who were examined from 2013 to 2017. One hundred and two patients (60%) had aortic balloon catheters placed before cesarean section (balloon group), and the other patients did not undergo balloon placement (control group). Clinical records from 170 subjects were reviewed. Results: Forty-nine patients were diagnosed as having placenta accreta (28.8%), 98 patients had placenta increta (57.6%), and 23 patients had placenta percreta (13.6%). Considering all subjects, the patients in the balloon group had a significantly reduced median estimated blood loss (p < 0.01), rate of transfusion (p = 0.02), amount of packed red blood cells (PRBCs) (p = 0.02), and decrease in hemoglobin levels (p = 0.03). Nine (8.8%) patients had catheterization-related complications, including eight cases of arterial or venous thrombosis. When the data were analyzed separately according to the different forms of abnormal invasive placenta, no difference in these surgical outcomes was observed between the two groups for women with placenta accreta or placenta percreta; however, for women with placenta increta who underwent IABO, the authors observed significant reductions in the estimated blood loss (p < 0.01), the amount of transfused PRBCs (p = 0.01), the extent to which hemoglobin levels decreased after surgery (p = 0.01), and the incidence of cesarean hysterectomy (p = 0.04). Conclusions: Although IABO was efficacious in both reducing intraoperative hemorrhage and blood transfusion, and in preventing hysterectomy during cesarean section for placenta increta, it should only be used on the basis of an accurate antenatal diagnosis, as it has a high risk of thrombosis and a high cost; immediate cesarean hysterectomy still seems to be the optimal management for placenta percreta.

Key words:  Aorta occlusion      Abnormal invasive placenta      Balloon catheter      Caesarean section      Placenta accreta     
Published:  10 October 2019     
*Corresponding Author(s):  L. XIE     E-mail:  841423692@qq.com

Cite this article: 

Z.R. Zheng, X. Xie, Y. Hou, P. Xie, X. Yu, L. Xie. Intraoperative infrarenal aortic balloon occlusion in pregnancies with placenta accreta, increta, and percreta. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 704-708.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4723.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I5/704

[1] Shi-Fu Hu, Ying-Ying Wang, Yan-Qing Wu, Qiong Yu. Timing of prophylactic antibiotic use during elective caesarean section: a meta-analysis of randomised controlled trials[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 31-36.
[2] Dubravko Habek, Matija Prka, Anto Čartolovni, Anis Cerovac, Domagoj Dokozić. Caesarean section between doctrine to heresis. Medicoethical and deontological view of caesarology: an opinion[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 1-4.
[3] G. Garuti, E. Castellacci, S. Calabrese, S. Calzolari. Hysteroscopic removal of retained products of conception with enhanced vascularity: a study of reliability[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 472-477.
[4] K. Tamura, H. Takahashi, S. Uchida, M. Ogoyama, R. Usui, S. Matsubara. Intrauterine balloon failure: unrecognized placenta accreta spectrum disorders[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 405-408.
[5] B. Díaz-Rabasa, R. Crespo Esteras, A. Agustín-Oliva, R.A. Laborda Gotor, P. Tobías González, C. De Bonrostro Torralba, S. Castán Mateo. Has advanced maternal age a real impact on intrapartum caesarean rate?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 55-59.
[6] X.W. Sun, X.M. Bai, Q. Chen, J.F. Shen, L. Yang, J.Y. Zhang, X.S. Gu, Q. Yuan, J. Jing, Y. Jin. Preset catheter sheaths for uterine arterial embolization in the cesarean section of pernicious preplacental placenta: its application[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 108-112.
[7] A. Tsiola, D. Marioli, I. Papadimitriou, V. Tsapanos, N. A. Georgopoulos. Increased kisspeptin mRNA expression derived from abnormally adhered placenta: compensatory inhibition of abnormal placental invasion?[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 204-208.
[8] A.S. Adlan, M.F. Zainal Abidin, C.C.W. Yim. Difference in outcomes of category 1 caesarean section patients in relation to type of anaesthesia administered: a tertiary university hospital experience[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 245-248.
[9] H. Kyozuka, K. Takiguchi, A. Owada, Y. Endo, M. Kojima, S. Suzuki, K. Fujimori. Two cases of placenta accreta with conservative management[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 283-286.
[10] S. Aslam, D. Al-Jaroudi. Women's involvement with the decision of caesarean section and their degree of satisfaction[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 88-92.
[11] A. Okada, K. Tanaka, K. Kajitani, S. Nishimoto, H. Nakamura, O. Nakamoto. Near-infrared spectroscopy during cesarean section with common iliac artery balloon occlusion for total placenta previa: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 112-114.
[12] B. Tuncali. A rare cause of intractable tachycardia during caesarean section: acute cannabis use[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 804-805.
[13] D.R. Listijono, S.C. Chuah, F. Rahimpanah. Management of placenta accreta in an Australian tertiary referral centre: a ten-year experience[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 374-378.
[14] H. Takahashi, R. Usui, H. Suzuki, Y. Baba, T. Suzuki, T. Kuwata, A. Ohkuchi, S. Matsubara. Uterine-fundal hypoechoic mass: a possible ultrasound sign for cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 88-92.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Prakash C. Deedwania. Management of Patients With Stable Angina and Type 2 Diabetes[J]. Reviews in Cardiovascular Medicine, 2015, 16(2): 105 -113 .
[5] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[6] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[7] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[8] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[9] . SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51 -52 .
[10] Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68 -70 .